Xu Z - Search Results

1

Connexin32 Promotes the Activation of Foxo3a to Ameliorate Diabetic Nephropathy via Inhibiting the Polyubiquitination and Degradation of Sirt1.

Li S, Xiao H, Sun X, Chen Z, Lin Z, Li C, Zeng J, Xu Z, Cheng Y, Huang H. Li S, et al. Among authors: xu z. Antioxid Redox Signal. 2023 Aug;39(4-6):241-261. doi: 10.1089/ars.2022.0108. Epub 2023 Apr 3. Antioxid Redox Signal. 2023. PMID: 36601735

2

Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway.

Chen ZQ, Sun XH, Li XJ, Xu ZC, Yang Y, Lin ZY, Xiao HM, Zhang M, Quan SJ, Huang HQ. Chen ZQ, et al. Acta Pharmacol Sin. 2020 Dec;41(12):1587-1596. doi: 10.1038/s41401-020-0475-6. Epub 2020 Jul 28. Acta Pharmacol Sin. 2020. PMID: 32724174 Free PMC article.

3

Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.

Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H. Xiao H, et al. Among authors: xu z. Acta Pharm Sin B. 2022 Jun;12(6):2887-2904. doi: 10.1016/j.apsb.2021.12.023. Epub 2022 Jan 6. Acta Pharm Sin B. 2022. PMID: 35755276 Free PMC article.

4

Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway.

Xu Z, Zhang M, Wang Y, Chen R, Xu S, Sun X, Yang Y, Lin Z, Wang S, Huang H. Xu Z, et al. Among authors: xu s. Front Pharmacol. 2022 Jun 23;13:848915. doi: 10.3389/fphar.2022.848915. eCollection 2022. Front Pharmacol. 2022. PMID: 35814242 Free PMC article.

5

Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis.

Li S, Lin Z, Xiao H, Xu Z, Li C, Zeng J, Xie X, Deng L, Huang H. Li S, et al. Among authors: xu z. Metabolism. 2023 Feb;139:155378. doi: 10.1016/j.metabol.2022.155378. Epub 2022 Dec 17. Metabolism. 2023. PMID: 36538986

6

Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis.

Zeng J, Liang L, Chen R, Li C, Pan L, Wen M, Lv D, Liu M, Xu Z, Huang H. Zeng J, et al. Among authors: xu z. Eur J Pharmacol. 2023 Sep 15;955:175915. doi: 10.1016/j.ejphar.2023.175915. Epub 2023 Jul 17. Eur J Pharmacol. 2023. PMID: 37467841

7

The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy.

Lin Z, Li S, Xiao H, Xu Z, Li C, Zeng J, Wang S, Liu Z, Huang H. Lin Z, et al. Among authors: xu z. Cell Rep. 2023 Aug 29;42(8):112851. doi: 10.1016/j.celrep.2023.112851. Epub 2023 Jul 22. Cell Rep. 2023. PMID: 37481723 Free article.

8

Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism.

Pan L, Xu Z, Wen M, Li M, Lyu D, Xiao H, Li Z, Xiao J, Cheng Y, Huang H. Pan L, et al. Among authors: xu z. Chin Med. 2024 Jun 11;19(1):82. doi: 10.1186/s13020-024-00959-1. Chin Med. 2024. PMID: 38862959 Free PMC article.

9

Gentiopicroside ameliorates glucose and lipid metabolism in T2DM via targeting FGFR1.

Xu Z, Huang J, Wen M, Zhang X, Lyu D, Li S, Xiao H, Li M, Shen C, Huang H. Xu Z, et al. Phytomedicine. 2024 Sep;132:155780. doi: 10.1016/j.phymed.2024.155780. Epub 2024 May 27. Phytomedicine. 2024. PMID: 38885580

10

Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-κB pathway.

Wen M, Sun X, Pan L, Jing S, Zhang X, Liang L, Xiao H, Liu P, Xu Z, Zhang Q, Huang H. Wen M, et al. Among authors: xu z. Eur J Pharmacol. 2024 Sep 5;978:176799. doi: 10.1016/j.ejphar.2024.176799. Epub 2024 Jun 29. Eur J Pharmacol. 2024. PMID: 38945289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,121 results

Search Page

Filters